Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that the Intraocular Pressure (IOP) lowering
efficacy of Travoprost Ophthalmic Solution 0.004% is superior to that of Pilocarpine 1% in
patients with chronic angle-closure glaucoma (CACG).